A study reveals nearly half of AI medical devices authorized by the FDA lack clinical validation data, raising concerns about their effectiveness and safety. Researchers call for clearer standards in clinical validation, emphasizing the need for the FDA to differentiate among retrospective, prospective, and randomized controlled trials.